267 related articles for article (PubMed ID: 32023884)
1. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
[No Abstract] [Full Text] [Related]
2. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.
Uen YH; Lin KY; Sun DP; Liao CC; Hsieh MS; Huang YK; Chen YW; Huang PH; Chen WJ; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2013 May; 83():197-213. PubMed ID: 23541716
[TBL] [Abstract][Full Text] [Related]
4. A proteomic classifier panel for early screening of colorectal cancer: a case control study.
Hua H; Wang T; Pan L; Du X; Xia T; Fa Z; Gu L; Gao F; Yu C; Gao F; Liao L; Shen Z
J Transl Med; 2024 Feb; 22(1):188. PubMed ID: 38383428
[TBL] [Abstract][Full Text] [Related]
5. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
[TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
[TBL] [Abstract][Full Text] [Related]
9. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
Lee PY; Chin SF; Low TY; Jamal R
J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
[TBL] [Abstract][Full Text] [Related]
10. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.
Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ
Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
12. Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients.
Choi JW; Liu H; Shin DH; Yu GI; Hwang JS; Kim ES; Yun JW
Proteomics; 2013 Aug; 13(15):2361-74. PubMed ID: 23606366
[TBL] [Abstract][Full Text] [Related]
13. Co-expression Network Analysis Identified Key Proteins in Association With Hepatic Metastatic Colorectal Cancer.
Yang W; Shi J; Zhou Y; Liu T; Li J; Hong F; Zhang K; Liu N
Proteomics Clin Appl; 2019 Nov; 13(6):e1900017. PubMed ID: 31397080
[TBL] [Abstract][Full Text] [Related]
14. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
[TBL] [Abstract][Full Text] [Related]
15. Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
Yang W; Shi J; Zhou Y; Liu T; Zhan F; Zhang K; Liu N
Int J Oncol; 2019 Aug; 55(2):439-450. PubMed ID: 31268166
[TBL] [Abstract][Full Text] [Related]
16. The potential role of ORM2 in the development of colorectal cancer.
Zhang X; Xiao Z; Liu X; Du L; Wang L; Wang S; Zheng N; Zheng G; Li W; Zhang X; Dong Z; Zhuang X; Wang C
PLoS One; 2012; 7(2):e31868. PubMed ID: 22363757
[TBL] [Abstract][Full Text] [Related]
17. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease-A Proteome Analysis of Cerebrospinal Fluid.
Kashiwazaki D; Uchino H; Kuroda S
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2981-2987. PubMed ID: 28843803
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.
Wang Y; Shan Q; Hou G; Zhang J; Bai J; Lv X; Xie Y; Zhu H; Su S; Li Y; Zi J; Lin L; Han W; Zhao X; Wang H; Xu N; Wu L; Lou X; Liu S
J Proteomics; 2016 Jan; 132():31-40. PubMed ID: 26581642
[TBL] [Abstract][Full Text] [Related]
20. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]